Search ETST
Earth Science Tech, Inc.
OTC · CIK 1538495
Last close0.09
Daily change+0.00 (0.00%)
10 Years gain-81.78%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ETST · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 0331
Fundamental
78.1Momentum
n/aAcceleration
n/aConfidence
73.0Annual Revenue13
Quarterly Revenue43
Annual CFO13
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth23.2 / 25
Quality16.0 / 25
Capital Efficiency20.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 0.5056 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 4.2541%.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Key Metrics
Revenue Growth TTM15.65%OK
Revenue CAGR 3Y802.64%OK
Gross Margin72.36%OK
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-4.25%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Mar 31, 2026 | $35.70M | $25.49M | n/a | $1.94M | $1.18M | 71.4% | n/a | 3.32% | n/a | 293.07M |
| 2026 FY Mar 31, 2025 | $33.12M | $24.30M | n/a | $4.37M | $3.62M | 73.38% | n/a | 10.93% | n/a | 303.52M |
| 2024 FY Mar 31, 2024 | n/a | n/a | $892,349.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| 2025 FY Mar 31, 2024 | $11.95M | $7.83M | n/a | $1.21M | n/a | 65.49% | n/a | n/a | n/a | 309.69M |
| 2024 FY Mar 31, 2023 | $48,537.00 | $22,060.00 | -$936,683.00 | -$1.01M | n/a | 45.45% | -1,929.83% | n/a | -175.91% | 145.87M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $35.22M | sum latest 4 fiscal quarters Revenue | OK | 0001493152-26-036450, 0001493152-25-021677 |
| Revenue Growth TTM | 15.65% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001493152-26-036450, 0001493152-25-021677 |
| Revenue CAGR 3Y | 802.64% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-029160 |
| Revenue CAGR 5Y | 202.51% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001493152-26-029160 |
| Gross Profit CAGR 3Y | 949.33% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-029160 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 72.36% | Gross Profit / Revenue | OK | 0001493152-26-036450, 0001493152-25-021677 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001493152-26-036450 |
| Current Ratio | 1.77x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.12 | Revenue / Diluted Shares | OK | 0001493152-26-036450, 0001493152-25-021677 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001493152-26-029160 |
| Diluted EPS TTM | $0.01 | Net income TTM / Diluted shares | OK | 0001493152-26-036450, 0001493152-25-021677 |